Trial Profile
An Open-Label Pharmacokinetic Drug Interaction Study of Folic Acid and 250 Mcg NGM/35 Mcg EE (ORTHO-CYCLEN) in Healthy Women
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Ethinylestradiol/norgestimate (Primary) ; Folic acid
- Indications Congenital abnormalities; Pregnancy
- Focus Pharmacokinetics
- Sponsors Janssen Research & Development
- 28 Apr 2010 Actual patient number (47) added as reported by ClinicalTrials.gov.
- 29 Jul 2008 New trial record.